Stockreport

New breast cancer combo sees success in New York trial [Yahoo! Finance]

Myriad Genetics, Inc.  (MYGN) 
Last myriad genetics, inc. earnings: 2/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: myriad.com/news-center/investor-information
PDF living with triple-negative breast cancer (TNBC) which saw 66% of its cohort achieving some form of remission. The research (NCT04081389), carried out by clinicians at [Read more]